Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuroscience ; 274: 229-41, 2014 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-24881576

RESUMO

Zellweger syndrome (ZS) is a severe peroxisomal disorder caused by mutations in peroxisome biogenesis, or PEX, genes. A central hallmark of ZS is abnormal neuronal migration and neurodegeneration, which manifests as widespread neurological dysfunction. The molecular basis of ZS neuropathology is not well understood. Here we present findings using a mouse model of ZS neuropathology with conditional brain inactivation of the PEX13 gene. We demonstrate that PEX13 brain mutants display changes that reflect an abnormal serotonergic system - decreased levels of tryptophan hydroxylase-2, the rate-limiting enzyme of serotonin (5-hydroxytryptamine, 5-HT) synthesis, dysmorphic 5-HT-positive neurons, abnormal distribution of 5-HT neurons, and dystrophic serotonergic axons. The raphe nuclei region of PEX13 brain mutants also display increased levels of apoptotic cells and reactive, inflammatory gliosis. Given the role of the serotonergic system in brain development and motor control, dysfunction of this system would account in part for the observed neurological changes of PEX13 brain mutants.


Assuntos
Encéfalo/patologia , Neurônios Serotoninérgicos/patologia , Síndrome de Zellweger/patologia , Animais , Apoptose , Axônios/metabolismo , Axônios/patologia , Encéfalo/metabolismo , Contagem de Células , Modelos Animais de Doenças , Imunofluorescência , Gliose/metabolismo , Gliose/patologia , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Camundongos Transgênicos , Mutação , Neuroimunomodulação/fisiologia , Peroxissomos/metabolismo , Neurônios Serotoninérgicos/metabolismo , Triptofano Hidroxilase/deficiência , Síndrome de Zellweger/metabolismo
2.
Neuroscience ; 192: 652-60, 2011 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-21704679

RESUMO

Traumatic injury to the brain initiates an increase in astrocyte and microglial infiltration as part of an inflammatory response to injury. Increased astrogliosis around the injury impedes regeneration of axons through the injury, while activated microglia release inflammatory mediators. The persistent inflammatory response can lead to local progressive cell death. Modulating the astrocyte and microglial response to traumatic injury therefore has potential therapeutic benefit in brain repair. We examine the modulatory effect of a single bolus of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) in combination on astrocytes and microglia to acute cerebral injury. A combination of VEGF and PDGF (20 pg) was injected into the striatum of adult male Sprague-Dawley rats. The effects of treatment were assessed by quantitative immunofluorescence microscopy analyzing astrocytes and microglia across the stab injury over time. Treatment delayed the onset of astrogliosis in the centre and edge of the stab injury up to day 5; however, increased astrogliosis at areas remote to the stab injury up to day 5 was observed. A persistent astrocytic response was observed in the centre and edge of the stab injury up to day 60. Treatment altered microglia cell morphology and numbers across the stab injury, with a decrease in ramified microglia, but an increase in activated and phagocytic microglia up to day 5 after stab injury. The increased microglial response from 10 until day 60 was comprised of the ramified morphology. Thus, VEGF and PDGF applied at the same time as a stab injury to the brain initially delayed the inflammatory response up to day 5 but evoked a persistent astrogliosis and microglial response up to 60 days.


Assuntos
Lesões Encefálicas/patologia , Neuroglia/patologia , Fator de Crescimento Derivado de Plaquetas/farmacologia , Fator A de Crescimento do Endotélio Vascular/farmacologia , Animais , Inflamação/tratamento farmacológico , Masculino , Microscopia de Fluorescência , Neuroglia/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Ferimentos Perfurantes/patologia
3.
Neurogastroenterol Motil ; 15(4): 383-92, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12846726

RESUMO

Intrinsic neurones of the gall bladder modulate its function. Nitric oxide synthase (NOS) and vasoactive intestinal polypeptide (VIP) are present in gall bladder neurones and nitric oxide and VIP modulate its epithelial functions. As an extensive extrinsic innervation of the gall bladder is also present, the source of the epithelial innervation is unclear. In this study the source of the gall bladder epithelial innervation is defined. Immunoreactivity for VIP, NOS, substance P (SP), calcitonin gene related peptide (CGRP) and tyrosine hydroxylase (TH) in organotypic cultured and freshly fixed gall bladder were compared. Retrograde tracing in vitro from the epithelium was used to identify putative intrinsic secretomotor neurones, which were then characterized by immunohistochemistry. Abundant spinal afferent and sympathetic innervation of the gall bladder epithelium was demonstrated by CGRP/SP and TH immunohistochemistry, respectively. The intrinsic secretomotor innervation of the epithelium is derived exclusively from neurones of the subepithelial plexus. A majority of these neurones were immunoreactive for NOS. Some of the NOS-immunoreactive neurones of the subepithelial plexus also contained VIP and/or SP. Gall bladder subepithelial plexus neurones, containing NOS and/or VIP/SP, innervate the epithelium, as do extrinsic neurones.


Assuntos
Vesícula Biliar/inervação , Vesícula Biliar/metabolismo , Gambás/anatomia & histologia , Animais , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Células Cultivadas , Epitélio/inervação , Epitélio/metabolismo , Vesícula Biliar/citologia , Imuno-Histoquímica , Neurônios Aferentes/metabolismo , Neurônios Aferentes/ultraestrutura , Óxido Nítrico Sintase/metabolismo , Gambás/fisiologia , Substância P/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo , Peptídeo Intestinal Vasoativo/metabolismo , Fibras Aferentes Viscerais/citologia , Fibras Aferentes Viscerais/metabolismo
4.
Auton Autacoid Pharmacol ; 22(2): 109-17, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12568128

RESUMO

1 The aim of this study was to determine if stimulation of duodenal motility by duodenal fluid distension or by administration of carbachol, activates the sphincter of Oddi-duodenal reflex, in an in vitro preparation from the Australian possum. 2 Duodenal distension was achieved by infusion of Krebs solution (0-8 cm H2O). In separate experiments, the sphincter of Oddi (SO) was partitioned from the duodenum and carbachol (10(-7) - 5 x 10(-6) M) added to the duodenal compartment. 3 Fluid distension increased duodenal motility to 120-600% of control activity. These treatments induced increased SO motility (to 120-390% of control) in six preparations, reduced activity (to 60% of control) in one and no response in another. 4 Addition of carbachol to the duodenal compartment resulted in increased duodenal motility. SO motility was increased in seven preparations, reduced in another two and no response were evoked in two others. All SO responses were blocked by tetrodotoxin pretreatment. 5 These data suggest that the SO receives inputs from duodenal mechano and/or stretch receptors resulting in excitatory or inhibitory responses, with the excitatory response dominating. These findings support the role for the SO-duodenal reflex in preventing duodenobiliary/pancreatic reflux during periods of elevated duodenal activity.


Assuntos
Duodeno/fisiologia , Motilidade Gastrointestinal/fisiologia , Reflexo/fisiologia , Esfíncter da Ampola Hepatopancreática/fisiologia , Animais , Carbacol/farmacologia , Duodeno/efeitos dos fármacos , Feminino , Motilidade Gastrointestinal/efeitos dos fármacos , Técnicas In Vitro , Masculino , Gambás , Pressão , Reflexo/efeitos dos fármacos , Esfíncter da Ampola Hepatopancreática/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...